NYSE$SYK

Stryker Corp · Q1 2020 earnings

Q1 2020 earnings · · Investor relations

Briefing

Stryker's Q1 2020 results were affected by the COVID-19 pandemic, but the company reported a net sales increase and earnings growth.

Stryker reported a 2.0% increase in net sales, reaching $3.6 billion. Despite the negative impact of the COVID-19 pandemic, the company's reported EPS increased by 19.3% to $1.30, and net earnings increased by 19.7% to $493 million.

  • Net sales increased by 2.0% to $3.6 billion.
  • Organic net sales increased by 2.4%.
  • Reported EPS increased by 19.3% to $1.30.
  • Net earnings of $493 million, an increase of 19.7%.

Headline financials

Total Revenue

$3.59B

Previous: $3.52B+2.0%
EPS (adj)

$1.84

Previous: $1.88-2.1%
Organic Net Sales Growth

2.4%

No prior period
Capital Expenditures

-$144M

Previous: -$122M-18.0%
Free Cash Flow

$349M

Previous: $290M+20.3%
Net Income

$493M

Previous: $412M+19.7%
Operating Income

$635M

Previous: $528M+20.3%
Gross Profit

$2.33B

Previous: $2.28B+2.1%
Cash & Equivalents

$3.96B

Previous: $1.67B+136.8%
Total Assets

$29.4B

Previous: $25.9B+13.5%
Stock-Based Comp

$56M

Previous: $35M+60.0%

Revenue & EPS history

Stryker · Revenue · Quarterly

$3.59B

Q1 2020+2%vs Q1 2019
Beat estimate in 16 of 16 quarters(100%)
ActualEstimate

Revenue by segment

Stryker · $1.22B total across 1 segment · Q1 2020

  • Orthopaedics
    $1.22B

Forward guidance

Due to the uncertain scope and duration of the pandemic, and uncertain timing of global recovery and economic normalization, Stryker will not be providing second quarter or full-year organic sales growth or earnings guidance for 2020.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q1 2020

Historical avgQ1 2020

+0.7%

Avg return

Earnings day

+0.3%

Avg return

5 days after

+1.7%

Avg return

30 days after

58%

42 / 73 earnings

Positive

+11.8%

Q4 2022

Best reaction

-6.3%

Q1 2020

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+1.4%-7.2%-3.0%
Q4 2025+2.6%+1.8%+9.4%
Q3 2025-3.0%-3.1%+0.6%
Q2 2025+0.0%-0.4%+3.6%
Q1 2025+1.0%+2.7%+2.3%
Q4 2024-2.2%-2.2%-2.8%
Q3 2024+2.1%+3.1%+9.0%
Q2 2024-1.7%-0.5%+7.4%
Q1 2024-3.2%-3.1%+0.5%
Q4 2023+6.7%+8.8%+11.0%
Q3 2023+1.5%+1.1%+9.5%
Q2 2023+3.3%+2.8%+3.6%
Q1 2023-1.9%-5.0%-8.0%
Q4 2022+11.8%+13.5%+5.0%
Q3 2022-4.0%-8.0%+2.0%
Q2 2022+5.1%+6.6%+7.5%
Q1 2022-3.2%-4.5%-5.1%
Q4 2021+0.1%+0.1%+7.1%
Q3 2021-0.9%+1.5%-9.3%
Q2 2021+2.0%+2.8%+2.9%
Q1 2021-2.1%-1.0%-4.1%
Q4 2020-3.4%-4.8%+2.0%
Q3 2020-1.4%+1.6%+13.6%
Q2 2020-4.0%-6.0%-1.6%
Q1 2020-6.3%-2.5%+1.6%
Q4 2019-1.8%-1.8%-9.2%
Q3 2019+1.6%-0.4%-4.1%
Q2 2019+0.4%+0.0%+0.2%
Q1 2019+1.6%+3.4%+1.3%
Q4 2018+10.7%+9.5%+16.4%
Q3 2018-1.7%-0.7%+1.0%
Q2 2018-2.7%-3.2%-3.0%
Q1 2018+3.2%+2.2%+5.1%
Q4 2017-2.6%-3.9%-5.6%
Q3 2017+6.4%+3.1%+3.0%
Q2 2017+1.4%+1.5%-4.0%
Q1 2017+1.3%+1.4%+4.8%
Q4 2016-0.2%+3.3%+3.6%
Q3 2016+4.0%+4.5%+2.7%
Q2 2016-4.4%-4.8%-7.0%
Q1 2016-0.4%
Q4 2015+4.4%
Q3 2015-5.4%
Q2 2015+2.5%
Q1 2015+3.3%
Q4 2014+0.2%
Q3 2014+1.0%
Q2 2014-0.2%
Q1 2014-1.1%
Q4 2013-1.0%
Q3 2013+2.7%
Q2 2013+2.2%
Q1 2013+1.1%
Q4 2012+2.8%
Q3 2012+0.3%
Q2 2012-2.9%
Q1 2012+2.2%
Q4 2011-0.0%
Q3 2011-2.9%
Q2 2011-0.3%
Q1 2011+0.2%
Q4 2010+1.9%
Q3 2010+2.3%
Q2 2010-0.7%
Q1 2009-1.1%
Q1 2010+0.2%
Q4 2009+1.9%
Q4 2007+1.9%
Q3 2008+2.9%
Q3 2009+2.9%
Q2 2009+5.1%
Q2 2008+5.1%
Q4 2008+5.1%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro